• Bain, B.J., Gilliland, D.G., Horny, H.P. & Vardiman, J.W. (2008) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 6873. IARC, Lyon.
  • Chaffanet, M., Popovici, C., Leroux, D., Jacrot, M., Adelaide, J., Dastugue, N., Gregoire, M.J., Hagemeijer, A., Lafage-Pochitaloff, M., Birnbaum, D. & Pebusque, M.J. (1998) t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene, 16, 945949.
  • Demiroglu, A., Steer, E.J., Heath, C., Taylor, K., Bentley, M., Allen, S.L., Koduru, P., Brody, J.P., Hawson, G., Rodwell, R., Doody, M.L., Carnicero, F., Reiter, A., Goldman, J.M., Melo, J.V. & Cross, N.C. (2001) The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood, 98, 37783783.
  • Jackson, C.C., Medeiros, L.J. & Miranda, R.N. (2010) 8p11 myeloproliferative syndrome: a review. Human Pathology, 41, 461476.
  • Patnaik, M.M., Gangat, N., Knudson, R.A., Keefe, J.G., Hanson, C.A., Pardanani, A., Ketterling, R.P. & Tefferi, A. (2010) Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. American Journal of Hematology, 85, 238242.
  • Wasag, B., Lierman, E., Meeus, P., Cools, J. & Vandenberghe, P. (2011) The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica, 96, 922926.